The Valley Desk

ArticleACR open rheumatologyPublished

Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
ACR open rheumatology
Published
PubMed ID
36880890
PubMed Central ID
PMC10100698
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal